RenovaroCube Unveils Research on Non-Invasive Cancer Diagnostics Utilizing Oxford Nanopore Sequencing at the Molecular Analysis for Precision Oncology Congress.
RenovaroCube presented groundbreaking research at the Molecular Analysis for Precision Oncology Congress, showcasing the efficacy of Oxford Nanopore sequencing on circulating cell-free DNA to detect key copy number alterations in lung cancer patients. This study highlights a significant advancement in non-invasive cancer diagnostics, aiming to improve patient-centered cancer care.
Company Information
Company
Renovaro
Location
Amsterdam, North Holland, Netherlands
About
Renovaro Inc. is a trailblazer in AI-driven early cancer diagnostics and therapeutics. The company aims to accelerate precision and personalized medicine for longevity, powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. RenovaroCube, as a molecular data science company, has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments.
Fundz sees it the moment Renovaro ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
AmsterdamBiotechnologyHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics